Skip Navigation
Skip to contents

KSC 2018

KSC 2018 : 대한심장학회 제62차 추계학술대회
10.11 Thu. - 13 Sat. / Grand Walkerhill Seoul, Korea

학술 프로그램

Home > Program > 학술 프로그램
08:40-10:10
Education Program New Frontiers in Cardiology 1 Past, Present and Future of Cardiology Theatre
Chairpersons Seung-Jung Park, Dae-Won Sohn, Moon-Hyoung Lee
Panel Il Suh, Tae Jin Youn, Young-Hoon Jeong, Iksung Cho
08:40-09:00 Past, Present and Future of Digital Medicine [Speaker] Evan Muse/Scripps Translational Science Institute, USA
09:00-09:20 Past, Present and Future of Myocardial Imaging [Speaker] Jeroen Bax/Leiden Univ., Netherlands
09:20-09:40 Past, Present and Future of Cardiac Epidemiology [Speaker] Katsuyuki Miura/Shiga Univ., Japan
09:40-10:00 Past, Present and Future of Antithrombotic Therapy [Speaker] Matthew Todd Roe/Duke Univ., USA
10:00-10:10 Discussion
Education Program Myocardial Infarction 1 The Burden of Myocardial Infarction in the World Grand 1
Chairpersons Myung Ho Jeong, Jin Yong Hwang
Panel Jong-Seon Park, Jang-Whan Bae, Seok Kyu Oh, Byung Ryul Cho
08:40-09:00 The Evolving Landscape of Myocardial Infarction Care and Outcomes in the United States: Insights from the ACTION and CathPCI Registries of the ACC-NCDR [Speaker] John A. Spertus/Saint Luke's Mid America Heart Institute, USA
09:00-09:20 Myocardial Infarction Outcomes in Singapore: Data from the National Registry and SingCLOUD [Speaker] Yeo, Khung Keong/National Heart Centre, Singapore
09:20-09:40 Pre-existing Chronic Kidney Disease Increases the Risk of Triggering Acute Myocardial Infarction Due to Asian Dust Exposure [Speaker] Sunao Kojima/Kawasaki Medical School, Japan
09:40-10:00 Current Status of Korean Registry of Acute Myocardial Infarction: Prospects and Barriers [Speaker] Juhan Kim/Chonnam National Univ., Korea
10:00-10:10 Discussion
Education Program Basic Research 1 Drug Development and Therapy Grand 2
Chairpersons Youngkeun Ahn, Jin Han
Panel TaeHoon Kim, Pil-Ki Min, Hun-Jun Park, Sung Woo Cho, Hyung Joon Joo
08:40-08:55 Cardiotoxicity Testing Using Human Pluripotent Stem Cell-derived Cardiomyocytes [Speaker] Gun Sik Cho/NEXEL, Korea
08:55-09:10 Mechanical Force-induced Activation of Platelet Integrin GPIIbIIIa [Speaker] Chungho Kim/Korea Univ., Korea
09:10-09:25 Identification of Indothiazinone as a Natural Antithrombotics [Speaker] Jong-Wha Jung/Kyungpook National Univ., Korea
09:25-09:40 Development of a Human “Kidney on a Chip” for Assessment of Drug/xenobiotic Toxicity [Speaker] Edward Kelly/University of Washington, USA
09:40-10:10 Discussion
Education Program Women Heart Disease 1 Gender and Medicine Grand 3
Chairpersons Vera Regitz-Zagrosek, Wan Joo Shim
Panel Ji-Young Park, Young Sup Byun, Mi Seung Shin, Hyun Ju Yoon, Kyung-Soon Hong
08:40-09:00 Gender Equality and Gender Dimension in Academic Research [Speaker] Vera Regitz-Zagrosek/University Medicine Berlin, PZHK, Germany
09:00-09:20 Gender Aspects of Korean Medical Students & Medical Edcuation [Speaker] Young-Mee Lee/Korea Univ., Korea
09:20-09:40 Personalized and Precision Medicine: The Importance of Sex and Gender [Speaker] Hack Lyoung Kim/Seoul National Univ., Korea
09:40-10:00 Gender Aspects of Risk Factors for Dementia [Speaker] Yi-Sook Jung/Ajou Univ., Korea
10:00-10:10 Discussion
Education Program Cardiometabolic Syndrome 1 Crosstalk between Vascular Calcification and Cardiometabolic Syndrome Grand 4
Chairpersons Kwang Kon Koh, Jae-Kwan Song
Panel Mi Jeong Kim, Sang-Hyun Ihm, Seung Hwan Han
08:40-09:05 Role of Vascular Smooth Muscle Cell Calcification [Speaker] Yabing Chen/University of Alabama at Birmingham, USA
09:05-09:20 Role of Progenitor Cells in Vascular Calcification [Speaker] Hyun-Jai Cho/Seoul National Univ., Korea
09:20-09:35 Aortic Valve Calcification and DPP4 Inhibition [Speaker] Bongkun Choi/Ulsan Univ., Korea
09:35-09:50 Inflammatory and Metabolic Mechanisms Underlying Calcific Aortic Valve [Speaker] Il Suk Sohn/Kyung Hee Univ., Korea
09:50-10:10 Discussion
Education Program Heart Failure 1 Multidisciplinary Team Approach in HF Management Walker 2
Chairpersons Young Dae Kim, Eun Seok Jeon
Panel Myung A Kim, Sang-Ho Jo, Eui-Young Choi, Kyung-Kuk Hwang
08:40-09:00 Multidisciplinary Team Approach: Tips and Pearls [Speaker] Jung Hyun Choi/Pusan National Univ., Korea
09:00-09:20 The Multidisciplinary Team Must Deliver Multifaceted Therapy [Speaker] John McMurray/University of Glasgow, UK
09:20-09:35 Role of Nurse Cordinator in HF Management [Speaker] Yeonsoo Jang/Yonsei Univ., Colleage of Nursing, Korea
09:35-09:50 Role of Clinical Exercise Physiologist in Heart Failure [Speaker] Kee Chan Joo/Seowon Univ., Korea
09:50-10:10 Discussion
Imaging 1 Multimodal Imaging Approach for Infiltrative Heart Disease Cosmos
Chairpersons 최연현, 조인호
Panel 구현정, 박철환, 조상건
08:40-09:00 Introduction of Infiltrative Heart Disease; Clinical and Pathololigical Viewpoint [Speaker] 이상철/성균관의대
09:00-09:20 Cardiac MRI in Infiltrative Heart Disease [Speaker] 정정임/가톨릭의대
09:20-09:40 Echo in the Diagnsis and Therapeutic Approach for Cardiac Sarcoidosis and Amyloidosis [Speaker] 심지영/연세의대
09:40-10:00 Recent Advances of Cardiac PET in Sarcoidosis and Amyloidosis [Speaker] 팽진철/서울의대
10:00-10:10 Discussion
10:20-11:50
Education Program Late Breaking & Featured Research from Asia-Pacific 1 Late Breaking & Featured Research from Asia-Pacific 1 Theatre
Chairpersons Si Hoon Park, Donghoon Choi
Panel Choong-Won 'Rick' Go, Moo Hyun Kim, Byeong-Keuk Kim, Young Hak Kim, Yongwhi Park, Ki Hong Lee, Young-Hoon Jeong, Jung Rae Cho
10:20-10:32 6-month Versus 12-month or Longer Dual Antiplatelet Therapy after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome (SMART-DATE): A Randomised, Open-label, Non-inferiority Trial [Speaker] Young Bin Song/Sungkyunkwan Univ., Korea
10:32-10:35 Critique [Speaker] Jung Rae Cho/Hallym Univ., Korea
10:35-10:38 Discussion
10:38-10:50 Ethnic Differences in Ischemia/Bleeding Tradeoff: Meta-Analysis of 7 RCTs [Speaker] Jeehoon Kang/Seoul National Univ., Korea
10:50-10:53 Critique [Speaker] Yongwhi Park/Gyeongsang National Univ., Korea
10:53-10:56 Discussion
10:56-11:08 Safety and Effectiveness of Second-Generation Drug-Eluting Stents in Patients with Left Main Coronary Artery Disease [Speaker] Pil Hyung Lee/Ulsan Univ., Korea
11:08-11:11 Critique [Speaker] Choong-Won 'Rick' Go/Hallym Univ., Korea
11:11-11:14 Discussion
11:14-11:26 COronary Computed Tomographic ANgiography for SElective Cardiac Catheterization Relation to CardioVascular Outcomesand Economics [Speaker] Hyuk-Jae Chang/Yonsei Univ., Korea
11:26-11:29 Critique [Speaker] Young Hak Kim/Ulsan Univ., Korea
11:29-11:32 Discussion
11:32-11:44 What Is the Ideal Blood Pressure in Patients with Atrial Fibrillation?: A Nationwide Cohort Study [Speaker] Boyoung Joung/Yonsei Univ., Korea
11:44-11:47 Critique [Speaker] Ki Hong Lee/Chonnam National Univ., Korea
11:47-11:50 Discussion
Education Program Intervention 1 40 Years of PCI: From Basic to Beyond Grand 1
Chairpersons David J. Moliterno, Seung-Jung Park
Panel Woong Chol Kang, Sung Woo Kwon, Kyung Soo Kim, Jang Ho Bae, Junghan Yoon, Seung Jea Tahk, Jung-Kyu Han
10:20-10:35 PCI as a Therapy: Avoiding the Oculo-stenotic Reflex and Tunel Vision [Speaker] Jun-Hee Lee/Hallym Univ., Korea
10:35-10:50 PCI Impact: Symptom, QOL, or Survival? [Speaker] John A. Spertus/Saint Luke's Mid America Heart Institute, USA
10:50-11:05 Using Imaging to Optimize Therapy: In What Situations Can IVUS/OCT Help Me? [Speaker] So-Yeon Choi/Ajou Univ., Korea
11:05-11:20 What Is FFR and How I Can Incorporate It into My Daily Practice? [Speaker] Joo Myung Lee/Sungkyunkwan Univ., Korea
11:20-11:35 40 Years of PCI: Where Next? [Speaker] Robert A. Byrne/Deutsches Herzzentrum Munchen, Germany
11:35-11:50 Discussion
Education Program Basic Research 2 The Fire of Life: Cardiac Energy Metabolism Grand 2
Chairpersons Ki Hwan Kwon, Seung Hwan Han
Panel Ki-Seok Kim, Yong Sook Kim, TaeHoon Kim , Hyoung Kyu Kim, Soon Jun Hong
10:20-10:35 Somatic Mutations That Contribute to Clonal Hematopoiesis and Cardio-metabolic Disease [Speaker] Kenneth Walsh/Boston Univ.,USA
10:35-10:50 White to Beige Conversion in PDE3B KO Adipose Tissue through Activation of AMPK Signaling and Mitochondrial Function [Speaker] Youn Wook Chung/Yonsei Univ., Korea
10:50-11:05 Disoriented Choline Metabolism Promotes Pathologies in the Failing Heart [Speaker] Ippei Shimizu/Niigata Univ., Japan
11:05-11:20 Enhanced-autophagy by Exenatide Mitigates Doxorubicin-induced Cardiotoxicity [Speaker] Kyung-Hye Lee/Kyung Hee Univ., Korea
11:20-11:50 Discussion
Women Heart Disease 2 Update CVD in Women Grand 3
Chairpersons 윤호중, 김명아
Panel 김미정, 나진오, 박상민, 박성지, 손일석
10:20-10:40 Are Women Adequately Diagnosed and Treated for Cardiovascular Diseases? [Speaker] Vera Regitz-Zagrosek/University Medicine Berlin, PZHK, Germany
10:40-11:00 Antihypertensive Drug Therapy in Women: Do We Really Need to Consider the Gender? [Speaker] 최성훈/한림의대
11:00-11:20 Sex Differences in Acute Decompensated Heart Failure [Speaker] 유승기/을지의대
11:20-11:40 Ischemia and Non-Obstructive CAD and Coronary Microvascular Dysfunction [Speaker] 박성미/고려의대
11:40-11:50 Discussion
Cardiometabolic Syndrome 2 Current Status of Cardiometabolic Syndrome Grand 4
Chairpersons 서홍석, 편욱범
Panel 박찬석, 손정우, 우종신, 최철웅
10:20-10:35 Diabetes Fact Sheet [Speaker] 이재혁/명지병원
10:35-10:50 Hypertension Fact Sheet [Speaker] 김현창/연세의대
10:50-11:05 Dyslipidemia Fact Sheet [Speaker] 유성훈/한양의대
11:05-11:20 Korea Survey of Cardiometabolic Syndrome, KSCMS Fact Sheet [Speaker] 성기철/성균관의대
11:20-11:35 Future Perspectives in Cardiometabolic Syndrome [Speaker] 김상현/서울의대
11:35-11:50 Discussion
Myocardial Infarction 2 Therapeutic Decisions beyond Guideline Grand 5
Chairpersons 김효수, 차광수
Panel 김원, 나득영, 이장훈, 이중희, 장기육
10:20-10:40 Invasive Strategies after NSTE-ACS: Timing and Controversies [Speaker] 허정호/고신의대
10:40-11:00 High-intensity Statins or Non-statin Combination in AMI: Which Do You Prefer? [Speaker] 심두선/전남의대
11:00-11:20 Mechanical Complication Management after AMI: Do’s and Don’ts [Speaker] 김정수/부산의대
11:20-11:40 Acute Cardiogenic Shock: Culprit Only vs. Immediate Multivessel PCI [Speaker] 윤창환/서울의대
11:40-11:50 Discussion
Arrhythmia 1 ECG Review Course Walker 1
Chairpersons 이명용, 장성원
[Speaker] 박예민/가천의대
[Speaker] 조영진/서울의대
[Speaker] 이광노/고려의대
[Speaker] 박종성/동아의대
[Speaker] 김동민/단국의대
[Speaker] 안진희/부산의대
[Speaker] 신동금/한림의대
[Speaker] 정래영/전북의대
[Speaker] 김기훈/인제의대
[Speaker] 이혜영/인제의대
Heart Failure 2 Advanced Heart Failure Walker 2
Chairpersons 유규형, 강석민
Panel 김경희, 김인철, 정욱진, 조양현
10:20-10:37 What's the Advanced Heart Failure? [Speaker] 윤종찬/한림의대
10:37-10:54 (Emerging) Pharmacological Tx for Advanced Heart Failure [Speaker] 이주희/충북의대
10:54-11:11 Current Problems of Heart Transplantation in Korea [Speaker] 최진오/성균관의대
11:11-11:28 Role of MCS in Advanced Heart Failure [Speaker] 정성호/울산의대
11:28-11:50 Discussion
Imaging 2 Coronary Artery Bypass Graft Surgery; Contemporary Practice in 2018 Cosmos
Chairpersons 송재관, 윤영남
Panel 김형관, 이원우, 정동섭, 팽진철
10:20-10:40 Myocardial Viability for Therapeutic Approach to Ischemic Heart Disease [Speaker] Jeroen Bax/Leiden Univ., Netherlands
10:40-11:00 Role of Radiologist in the Preoperative Assessment [Speaker] 서영주/연세의대
11:00-11:20 Recent Advance of SPECT and PET in Preoperative Assessment [Speaker] 조상건/전남의대
11:20-11:40 Prediction of Myocardial Viability; Case Presentation with Multi-modality Imaging Approach [Speaker] 최의영/연세의대
11:40-11:50 Discussion
12:00-12:40
Scientific Session 1 [Bayer] Tailored Protection for Your Cardio-Vascular Patients Theatre
Chairpersons 조정관, 전은석
12:00-12:20 Considering Renal Outcomes in Anticoagulation Treatment with Rivaroxaban [Speaker] 임홍의/고려의대
12:20-12:40 Evolving Antithrombotic Therapy for NVAF Patients with Heart Failure. Is It Enough? [Speaker] 최진오/성균관의대
Diamond Session [Pfizer/BMS] Strategies to Optimize Management of Atherosclerotic CVD and Stroke Prevention in Atrial Fibrillation Grand 1
Chairpersons 김영훈, 김효수
12:00-12:20 ASCOT Legacy: Long-term Survival Benefit of BP, Lipid Lowering [Speaker] 홍영준/전남의대
12:20-12:40 Choice of Antithrombotic Therapy in NVAF and Concomitant Coronary Artery Disease [Speaker] Ziad Hijazi/Uppsala Univ., Sweden
Scientific Session 2 [Daewoong/Daiichisankyo] Effective Treatments of Hypertension and Dyslipidemia Walker 1
Chairpersons 안태훈, 편욱범
12:00-12:20 Update in Hypertension Guideline [Speaker] 이해영/서울의대
12:20-12:40 ROSUVASTATIN In Early Prevention of CVD [Speaker] 성지동/성균관의대
Scientific Session 3 [Novartis] ARNI : PARADIGM Shift in Heart Failure Therapy Walker 2
Chairpersons 김기식, 김재중
12:00-12:30 Resolving Dilemmas in the Treatment of Heart Failure [Speaker] John McMurray/University of Glasgow, UK
12:30-12:40 Discussion
14:00-15:30
Education Program Cross Specialty 1 NOAC in CAD and PAD Theatre
Chairpersons Robert C. Welsh, Yun Shik Choi
Panel Hiroshi Ando, Robert A. Byrne, Jum Seok Ko, Jin-Seok Kim, Deuk Young Nah, Kyung Woo Park, So Ryoung Lee
14:00-14:15 NOAC Role in ACS: Alternative or Addictive to DAPT - Still Promising? [Speaker] Young-Hoon Jeong/Gyeongsang National Univ., Korea
14:15-14:30 NOAC for Stable CAD & PAD: COMPASS Impact in Real-World [Speaker] Matthew Todd Roe/Duke Univ., USA
14:30-14:45 Appropriate Anticoagulation in AF Patients Undergoing Procedure: PCI and Ablation [Speaker] Ki Hong Lee/Chonnam National Univ., Korea
14:45-15:00 Easy Tip to Use NOAC in AF Patients [Speaker] Jung Myung Lee/Kyung Hee Univ., Korea
15:00-15:15 Management of Bleeding in AF Patients with NOAC [Speaker] Myung-jin Cha/Seoul National Univ., Korea
15:15-15:30 Discussion
Myocardial Infarction 3 Current Practice and Debate Grand 1
Chairpersons 성인환, 박헌식
Panel 김용철, 이장훈, 조정래, 조진만, 황경국
14:00-14:20 Erosion or Plaque Rupture: Which Is It? How to Do? [Speaker] 윤혁준/계명의대
14:20-14:40 Aspiration Thrombectomy in Primary PCI: Dead or Alive? [Speaker] 김동기/인제의대
14:40-15:00 Chronic Use of Antiplatelet and Antithrombotic Therapies in AF PCI: Choice and Duration [Speaker] 박용휘/경상의대
15:00-15:20 Interrogation of Concomitant Non-culprit Stenoses in Patients with AMI: When and How? [Speaker] 안성균/연세원주의대
15:20-15:30 Discussion
Education Program JCS-KSC Joint Drug Discovery for Heart Failure Grand 2
Chairpersons Tohru Minamino, Sang Hong Baek
14:00-14:15 BIO((2’z, 3’E)-6-Bromoindirubin-3’-oxime) [Speaker] Youngkeun Ahn/Chonnam National Univ., Korea
14:15-14:30 Targeting Metabolites for HF Treatment [Speaker] Tohru Minamino/Niigata Univ., Japan
14:30-14:45 Cardiac Myosin Activator [Speaker] Eun Seok Jeon/Sungkyunkwan Univ., Korea
14:45-15:00 Hippo-YAP Pathway [Speaker] Norifumi Takeda/University of Tokyo, Japan
15:00-15:30 Discussion
Lipid 1 Progression and Regression of Atherosclerosis Grand 3
Chairpersons 김효수, 정익모
Panel 김주한, 김중선, 이은미, 최성훈, 최윤석
14:00-14:20 Lipid and Inflammation in Atherosclerosis [Speaker] 김장영/연세원주의대
14:20-14:40 Anti-inflammtory Therapy on Atherosclerosis [Speaker] 이왕수/중앙의대
14:40-15:00 What Do FOURIER or ODYSSEY Data Mean for Clinical Practice? [Speaker] 박훈준/가톨릭의대
15:00-15:20 Ongoing Development of New Therapy for Atherosclerosis [Speaker] 김상현/서울의대
15:20-15:30 Discussion
Echo 1 Imaging in Heart Failure Walker 2
Chairpersons 김기식, 신준한
Panel 김계훈, 신미승, 조구영
14:00-14:15 Echo in HFpEF [Speaker] 박찬석/가톨릭의대
14:15-14:30 Strain Imaging in HF [Speaker] 이주희/충북의대
14:30-14:45 Vortex Imaging in Heart Failure [Speaker] 홍그루/연세의대
14:45-15:00 Imaging for ECMO [Speaker] 손일석/경희의대
15:00-15:15 Imaging for LVAD [Speaker] 김은경/성균관의대
15:15-15:30 Discussion
Education Program Smart Healthcare Use of Smart Health Techonologies and Big Data Analysis for Cardiovascular Research Cosmos
Chairpersons Seung Woo Park, Hyuk-Jae Chang
Panel In-Cheol Kim, Hack Lyoung Kim, In-Jeong Cho
14:00-14:30 Improving Medical Adherence in Cardiovascular Disease Management with mHealth Technologies [Speaker] Evan Muse/Scripps Translational Science Institute, USA
14:30-14:50 Are There Differences in the Efficacy of Dual Combination of RAS Inhitors + CCBs, RAS Inhibitors + Diuretics vs CCBs + Diuretics for Treatment of Hypertension? Analysis from the OHDSI Network [Speaker] Sung Ha Park/Yonsei Univ., Korea
14:50-15:10 Application of EMR Based Big Data Registry for Cardiovascular Disease [Speaker] Hye Jin Kam/Health Innovation Bigdata Center, Asan Medical Center, Korea
15:10-15:30 Discussion
15:40-17:10
Late Breaking & Featured Research from Korea Late Breaking & Featured Research from Korea Theatre
Chairpersons 심완주, 안영근
Panel 권택근, 김송이, 박근호, 손일석, 이진배, 최종일, 한진, 홍영준
15:40-15:55 Role of Cardiac Fibroblast in Pressure Induced Cardiac Injury [Speaker] Ki-Seok KIM
15:55-16:00 Discussion
16:00-16:15 Identification on Preventive Mechanism of Sodium-glucose Cotransporter 2 (SGLT-2) Inhibitor for Atherosclerosis in Normoglycemic Rabbit Model [Speaker] Jung-Sun KIM
16:15-16:20 Discussion
16:20-16:35 The Feasibility of Handgrip Exercise Echocardiography for Detection of Heart Failure with Preserved Ejection Fraction Compared to Supine Bicycle Exercise Cardiac Catheterization Test [Speaker] Seok-Jae HWANG
16:35-16:40 Discussion
16:40-16:55 Cardioprotective Potential of an SGLT2 Inhibitor Against Doxorubicin-induced Heart Failure SGLT2 Inhibitor Prevents Doxorubicin-induced Cardiotoxicity [Speaker] Sungsoo CHO
16:55-17:00 Discussion
Education Program Intervention 2 Hot Issues in Antithrombotic Therapy Grand 1
Chairpersons Matthew Todd Roe, Yangsoo Jang
Panel Robert C. Welsh, Kyung Woo Park, Duk Woo Park, Yongwhi Park, Jong-Seon Park, Jang-Whan Bae, Young Bin Song, Young-Hoon Jeong
15:40-15:55 Expanding the Role of NOACs: Post PCI and Post TAVR? [Speaker] David J. Moliterno/University of Kentucky, USA
15:55-16:10 Expanding the Role of NOACs: ACS and ASCVD [Speaker] Matthew Todd Roe/Duke Univ., USA
16:10-16:25 P2Y12 Escalation and De-Escalation Strategy in Clinical Practice [Speaker] Jung Rae Cho/Hallym Univ., Korea
16:25-16:40 New Trials on P2Y12 Intensity and Durations: GLOBAL-LEADER, TWILIGHT, and More [Speaker] Robert A. Byrne/Deutsches Herzzentrum Munchen, Germany
16:40-16:55 Criteria and Clinical Decision for DAPT Duration after PCI [Speaker] Kyung Woo Park/Seoul National Univ., Korea
16:55-17:10 Discussion
Lipid 2 Cardiometabolic Risk Factors beyond Lipids Grand 3
Chairpersons 김치정, 최동훈
Panel 강현재, 임영효, 조현재, 홍순준
15:40-16:00 Epidemiologic Assessment of the Main Determinants of Cardiometabolic Disease [Speaker] 최윤석/가톨릭의대
16:00-16:20 The Role of Diet in Cardiometabolic Disease [Speaker] 신민정/고려대학교
16:20-16:40 Exercise for the Cardiometabolic Disease [Speaker] 김영주/성신여대
16:40-17:00 Gut Microbiome and Cardiometabolic Disease [Speaker] 주형준/고려의대
17:00-17:10 Discussion
Arrhythmia 2 Stroke Summit Walker 1
Chairpersons 김준수, 김대경
Panel 강구현, 권창희, 백용수, 이찬희, 차명진
15:40-15:50 Care Burden of AF [Speaker] 양필성/차의대
15:50-16:00 New AF Screening [Speaker] 김남호/원광의대
16:00-16:10 Risk Stratification of Stroke and Thromboembolism in AF [Speaker] 김태훈/연세의대
16:10-16:20 NOAC Use in Specific Conditions [Speaker] 진은선/경희의대
16:20-16:30 LAA Occluder [Speaker] 임홍의/고려의대
16:30-16:45 Korean AF Guideline [Speaker] 정보영/연세의대
16:45-17:10 Discussion
Education Program Echo 2 Valvular Heart Diseases Walker 2
Chairpersons Jong-Won Ha, Jong-Min Song
Panel Yong-Jin Kim, Tae-Ho Park, Sangchol Lee
15:40-15:55 Echocardiography in TAVR [Speaker] Woo-Baek Chung/Catholic Univ., Korea
15:55-16:10 Roles of CT and MRI for Aortic Valvular Stenosis Evaluation [Speaker] Yeon Hyen Choe/Sungkyunkwan Univ., Korea
16:10-16:25 Echocardiography in Mitral Regurgitation [Speaker] Chi Young Shim/Yonsei Univ., Korea
16:25-16:40 Echocardiography in Prosthetic Valves [Speaker] Sahmin Lee/Ulsan Univ., Korea
16:40-16:55 Intraoperative TEE; Case-based Learning [Speaker] Sung Ji Park/Sungkyunkwan Univ., Korea
16:55-17:10 Discussion
Education Program Epidemiology Improvement of CVD Prediction in the General Population Cosmos
Chairpersons Il Suh, Sang Hong Baek
Panel Young Hak Kim, Ki Chul Sung, Ju-Mi Lee
15:40-16:00 Improving Disease Prediction with Machine Learning [Speaker] Choongki Min/Selvas AI, Korea
16:00-16:20 CVD Predictions Using Repeatedly Measured Risk Factors [Speaker] Hyeon Chang Kim/Yonsei Univ., Korea
16:20-16:40 Imaging Techniques to Improve CVD Prediction [Speaker] Hyung-Bok Park/Catholic Kwandong Univ., Korea
16:40-17:00 The Improvement of CVD Prediction for Japanese Population [Speaker] Katsuyuki Miura/Shiga Univ., Japan
17:00-17:10 Discussion